Supporting
. Synthesis scheme. Synthesis scheme of bis-DPA (a), aminoethyl 5β-cholanoamide (EtCA) (b), HA-aminoethyl 5β-cholanoamide (HA-CA) conjugate (c) and bis-DPAfunctionalized HA nanoparticles (HDz-NP) (d). Figure S2 . Chemical structure and NMR spectrum. a, Chemical structure and examplary 1 H NMR spectrum of HA-CA modified with DPA (HD conjugate) (300 MHz, D 2 O/CD 3 OD). δ=6.8-8.3 ppm (methylene groups of the ring structure in bis-DPA), 2.0 ppm (the methyl group at the C2 position of Nacetyl glucosamine in HA), 0.6-1.8 ppm (methyl and methylene groups of the ring structure in CA). Figure S4 . RNA stability analyses. Gel electrophoretic retardation analyses (a) and relative siRNA amount (b). CaP-HDz/siRNA-NFs and free siRNA (15 pmol) were incubated in the mouse serum for 1, 6 and 24 h at 37 ºC. Moreover, to emulate endosome/lysosome acidic environment, the samples were incubated at pH 5 for 20 min, followed by siRNA evaluation. The CaP-HDz/siRNA samples contained significantly higher amount of intact siRNA than free siRNA samples after serum incubation. Figure S5 . Cellular uptake and RNA transfection. Quantitative flow cytometry results (a and b) and fluorescence images (c) of DU145 cancer cells treated with CaP-HDz/siRNA and Lipo2K/siRNA. Mean fluorescence intensity and fluorescence signals of the NP-treated cells were remarkably higher than Lipo2K-treated cells. d, Celluar images of HCT116 cells treated with Cy3-siRNA complexed with CaP-HDz-NP or Lipofectamine 2000 (Lipo2K); CD44-blocked cells treated with CaPHDz/siRNA or Cy3-siRNA only. Blue (DAPI, nuclei) and red (siRNA). The cells treated with CaPHDz/siRNA-NFs exhibited significantly stronger fluorescence signal than the cells treated with free siRNA or Lipo2K/siRNA. After CD44 receptors on the cell surface were blocked by pre-treatment of excess HA molecules, fluorescence signals from siRNA were rarely detected, indicating cell-permeation of CaPHDz/siRNA is highly dependant on the interaction between HA backbone of the NPs and CD44 cell surface receptors. Scale bar, 60 nm Supporting Figure S6 . Cellular imaging of endosomal escape. Fluorescence images of 143B osteosarcoma cells treated with CaP-HDz-Cy5.5/siRNA-Cy3. At 1 h post treatment, the NFs were found to be internalized into the cells, and the HDz-Cy5.5 (blue) and siRNA-Cy3 (red) signals were significantly co-localized, showing strong complexation between HDz and siRNA. Furthermore, HDz and siRNA signals were also co-localized with LysoTracker (cyan) signals that represent acidic cell compartments (late endosome or early lysosome), implying entrapment of NFs by endosomes (or lysosomes). After 6h incubation, considerable siRNA signals were separated from LysoTracker (cyan) signals and diffused into cytosol (white arrows), indicating endosomal escape of siRNA molecules. These images were also constructed into 3D Z-stack movies (supporting data). Scale bar indicates 30 nm scale. 

SUPPORTING INFORMATION DATA
Supporting Data 1. 3D Z-stack video of cellular uptake and endosomal escape (1 h incubation). 3D Z-stack video of 43B osteosarcoma cells treated with CaP-HDz-Cy5.5/siRNA-Cy3 after 1 h incubation with NFs. At 1 h post treatment, the NFs were found to be internalized into the cells, and the HDz-Cy5.5 (blue) and siRNA-Cy3 (red) signals were significantly co-localized, showing strong complexation between HDz and siRNA. Furthermore, HDz and siRNA signals were also co-localized with LysoTracker (cyan) signals that represent acidic cell compartments (late endosome or early lysosome), implying entrapment of NFs by endosomes (or lysosomes).
Supporting Data 2. 3D Z-stack video of cellular uptake and endosomal escape (6 h incubation).
After 6h incubation, considerable siRNA signals were separated from LysoTracker (cyan) signals and diffused into cytosol (white arrows), indicating endosomal escape of siRNA molecules. These images were also constructed into 3D movies (supporting data). Scale bar indicates 30 nm scale.
SUPPORTING INFORMATION METHODS
In Vitro Enzyme-Triggered Degradation and Drug Release Profiles of CaP-HDz/Drug/siRNA-NFs. Hyal-sensitive NF-degradation and consequent drug release profiles of CaP-HDz-Cy5.5/PTX-OG/siRNANFs were monitored using a Maestro all-optical imaging system. To estimate drug release profiles of CaP-HDz/PTX/siRNA-NFs with presence of Hyal, fluorescent images and quantification data of CaPHDz/PTX/siRNA-NFs solutions were obtained after the NF solutions were incubated with different concentrations (0, 2.5, 25, 250 unit/mL) of Hyal in an acetate buffer (pH = 4.3, 37 ºC) for an hour.
In Vitro Characterization of CaP-HDz/RNA-NFs. Nanoparticle formation of HDz, CaP-HDz and CaPHDz/RNAs was examined by atomic force microscopy (AFM). Size distribution of each formulation was measured by dynamic light scattering (DLS). RNA complexation with HDz or CaP-HDz was confirmed by zeta potential measurement. The RNA complexation and release behavior from HDz/RNA or CaPHDz/RNA nanoformulas were evaluated by gel electrophoresis. 3% agarose gel was prepared by dissolving agarose powder in Tris-acetate-EDTA buffer containing 0.5 µg/mL ethidium bromide. RNA was formulated with HDz nanoparticles by mixing HDz (2 µL, 1 mg/mL of HDz; 0.1 M ZNH) with RNA (1 µL, 10 µM) by gentle vortexing, which was followed by incubation at room temperature for 30 min. To prepare CaP-HDz/RNA complexes, we added Tris-calcium buffer (1 µL) and HEPES-phosphate buffer (4 µL) as described hereinbefore. To assess the decomplexation of siRNA, HDz/RNA or CaP-HDz/RNA was incubated with sodium phosphates (150 mM) or acetate buffer (200 mM, pH 5 or pH 6) for 15 min and the RNA release was monitored. Stability of siRNA complexed with CaP-HDz nanoparticles versus free siRNA (10pmol) was evaluated after incubation of the samples in 10 µL of mouse serum for 1, 6 and 24h at 37 °C, followed by incubation in the acidic media at pH 5 as previous described hereinbefore. siRNA complexed with Cap-HDz and free siRNA that were not incubated with serum but only incubated in the acidic media were used as control groups. RNA was analyzed by gel electrophoresis after DNA loading buffer (6x) was added to each sample. Gel electrophoresis was carried out at 100 V for 15 min, and the gel was imaged. Cellular Uptake and Transfection Study. Cellular uptake of CaP-HDz/RNA was assessed using confocal fluorescence microscopy. 2×10 5 of 143B or DU145 cells (MEM, 10% FBS) were seeded in eight-well multichamber slides (Nalgen Nunc International). We prepared CaP-HDz/Cy3-siRNA-NFs as described hereinbefore and dispersed the CaP-HDz/Cy3-siRNA, Lipo2K/Cy3-siRNA or free Cy3-siRNA (siRNA: 10 pmol) in 200 µl medium. Cells were washed 2 times with PBS buffer and treated with each sample. The cells were incubated at 37 ºC in a humidified 5% CO 2 atmosphere for 1 h and washed 3 times with PBS buffer. Intracellular fluorescence signals of cells after treated with Cy3-siRNA, Lipo2K/Cy3-siRNA or CaP-HDz/Cy3-siRNA were monitored under confocal fluorescence microscope. We also investigated endosomal escape profile of siRNA incorporated with CaP-HDz-NPs. 143B cells were prepared in the same manner as DU145/HCT116 cells, and the cells were treated with CaP-HDz/Cy3-siRNA-NFs (siRNA: 10 pmol) in 200 µl MEM medium containing LysoTracker Blue DND-22 (Invitrogen). Intracellular fates of the NFs were monitored by confocal fluorescence microscopy 1h and 6h after treatment. We further studied cellular uptake of CaP-HDz/RNA after blocking CD44 receptors on HCT116 cells with excess amount of free HA molecules (10 mg/mL). After 30 min incubation, the cells were treated with CaP-HDz/Cy3-siRNA and incubated for 1 h. Intracellular fluorescence signals were monitored by confocal fluorescence microscopy. To quantitatively analyze the transfection efficiency, we seeded cells in six well plates and transfected the cells, i.e. 143B, DU145 and HCT116 cells with CaP-
